Literature DB >> 10862579

Antiarrhythmics--from cell to clinic: past, present, and future.

J C Hancox1, K C Patel, J V Jones.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10862579      PMCID： PMC1729402          DOI： 10.1136/heart.84.1.14

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  88 in total

Review 1.  A classification of antiarrhythmic actions reassessed after a decade of new drugs.

Authors:  E M Vaughan Williams
Journal:  J Clin Pharmacol       Date:  1984-04       Impact factor: 3.126

Review 2.  The Na/K pump of cardiac cells.

Authors:  D C Gadsby
Journal:  Annu Rev Biophys Bioeng       Date:  1984

3.  Voltage- and time-dependent depression of maximum rate of depolarisation of guinea-pig ventricular action potentials by two new antiarrhythmic drugs, flecainide and lorcainide.

Authors:  T J Campbell; E M Vaughan Williams
Journal:  Cardiovasc Res       Date:  1983-05       Impact factor: 10.787

4.  Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassification.

Authors:  T J Campbell
Journal:  Cardiovasc Res       Date:  1983-06       Impact factor: 10.787

5.  The effects of lidocaine on intracellular and extracellular potentials, activation, and ventricular arrhythmias during acute regional ischemia in the isolated porcine heart.

Authors:  R Cardinal; M J Janse; I van Eeden; G Werner; C N d'Alnoncourt; D Durrer
Journal:  Circ Res       Date:  1981-09       Impact factor: 17.367

6.  Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias.

Authors:  J P diMarco; T D Sellers; B B Lerman; M L Greenberg; R M Berne; L Belardinelli
Journal:  J Am Coll Cardiol       Date:  1985-08       Impact factor: 24.094

7.  Efficacy and safety of intravenous and oral diltiazem for Wolff-Parkinson-White syndrome.

Authors:  M Shenasa; M Fromer; G Faugere; R Nadeau; R A Leblanc; C Lambert; M A Sadr-Ameli
Journal:  Am J Cardiol       Date:  1987-02-01       Impact factor: 2.778

8.  Resting and rate-dependent depression of maximum rate of depolarisation (Vmax) in guinea pig ventricular action potentials by mexiletine, disopyramide, and encainide.

Authors:  T J Campbell
Journal:  J Cardiovasc Pharmacol       Date:  1983 Mar-Apr       Impact factor: 3.105

9.  Quinidine blocks cardiac sodium channels during opening and slow inactivation in guinea-pig papillary muscle.

Authors:  L M Hondeghem; T Matsubara
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

10.  Stereoselective effects of disopyramide enantiomers in humans.

Authors:  J J Lima; H Boudoulas
Journal:  J Cardiovasc Pharmacol       Date:  1987-05       Impact factor: 3.105
View more
  6 in total

1.  Failure of plasma brain natriuretic peptide to identify left ventricular systolic dysfunction in the community.

Authors:  D J Hetmanski; N J Sparrow; S Curtis; A J Cowley
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

2.  Increased formation of F(2)-isoprostanes in patients with severe heart failure.

Authors:  J L Cracowski; F Tremel; C Marpeau; J P Baguet; F Stanke-Labesque; J M Mallion; G Bessard
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

3.  Reduction in Fas/APO-1 plasma concentrations correlates with improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy treated with pentoxifylline.

Authors:  D Skudicky; K Sliwa; A Bergemann; G Candy; P Sareli
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

Review 4.  Prophylactic Antiarrhythmic Drug Therapy in Atrial Fibrillation.

Authors:  Moisés Rodríguez-Mañero; Andrea Sarkozy; Gian-Battista Chierchia; Rubén Casado-Arroyo; Danilo Ricciardi; Carlo de Asmundis; Andrea Carlo de; Pedro Sarkozy
Journal:  J Atr Fibrillation       Date:  2013-02-12

Review 5.  Pilsicainide.

Authors:  Greg L Plosker
Journal:  Drugs       Date:  2010-03-05       Impact factor: 9.546

6.  Molecular basis of hERG potassium channel blockade by the class Ic antiarrhythmic flecainide.

Authors:  Dario Melgari; Yihong Zhang; Aziza El Harchi; Christopher E Dempsey; Jules C Hancox
Journal:  J Mol Cell Cardiol       Date:  2015-07-06       Impact factor: 5.000
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.